Inventor · disambiguated record
Charles Gluchowski
Also filed as: GLUCHOWSKI CHARLES
71 granted patents·19 pending applications·1,864 citations·filing 1986–2025
99Inventor score
Files withSYNAPTIC PHARMA CORP52ALLERGAN INC21OLIGOMERIX INC5MANIV ENERGY CAPITAL1SOLOW-CORDERO DAVID1
Top patents by PatentIndex Score
90 records- 0197US5034413AIntraocular pressure reducing 9,11-diacyl prostaglandinsALLERGAN INC·Filed 1990·Granted Jul 23, 1991·304 cites·33 claims
- 0296US6391877B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted May 21, 2002·52 cites·39 claims
- 0395US6723741B2Benzimidazoles and benzothiazoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Granted Apr 20, 2004·46 cites·17 claims
- 0495US6620815B1Oxazolidinones and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 16, 2003·50 cites·40 claims
- 0595US5021416AMethod for using (2-imidazolin-2-ylamino) quinoxalines to reduce or maintain intraocular pressureALLERGAN INC·Filed 1989·Granted Jun 4, 1991·99 cites·28 claims
- 0694US6720324B2Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Apr 13, 2004·51 cites·18 claims
- 0794US6211241B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·58 cites·11 claims
- 0891US6159998ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Dec 12, 2000·30 cites·13 claims
- 0991US5091528A6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agentsALLERGAN INC·Filed 1990·Granted Feb 25, 1992·87 cites·31 claims
- 1090US5403847AUse of α1C specific compounds to treat benign prostatic hyperlasiaSYNAPTIC PHARMA CORP·Filed 1992·Granted Apr 4, 1995·70 cites·52 claims
- 1190US5077292A(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using sameALLERGAN INC·Filed 1989·Granted Dec 31, 1991·44 cites·32 claims
- 1289US5130441AMethod for producing amino-2-imidazoline derivativesALLERGAN INC·Filed 1990·Granted Jul 14, 1992·39 cites·34 claims
- 1388US5237072AMethod for producing amino-2-imidazoline derivativesALLERGAN INC·Filed 1992·Granted Aug 17, 1993·32 cites·20 claims
- 1488US5198442A(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using sameALLERGAN INC·Filed 1992·Granted Mar 30, 1993·34 cites·20 claims
- 1587US6495583B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2002·Granted Dec 17, 2002·14 cites·13 claims
- 1687US5767131ADihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 1994·Granted Jun 16, 1998·38 cites·18 claims
- 1787US5204347AMethods for using (2-imidazolin-2-ylamino) tetrahydroquinoxalinesALLERGAN INC·Filed 1991·Granted Apr 20, 1993·31 cites·16 claims
- 1886US6245773B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Jun 12, 2001·34 cites·19 claims
- 1985US6159990AOxazolidinones as α1A receptor antagonistsSYNAPTIC PHARMA CORP·Filed 1998·Granted Dec 12, 2000·66 cites·38 claims
- 2084US5677321A5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligandsSYNAPTIC PHARMA CORP·Filed 1996·Granted Oct 14, 1997·38 cites·16 claims
- 2184US5300504A(2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using sameALLERGAN INC·Filed 1992·Granted Apr 5, 1994·44 cites·14 claims
- 2283US5610174AUse of α1A -selective adrenoceptor agonists for the treatment of urinary incontinenceSYNAPTIC PHARMA CORP·Filed 1995·Granted Mar 11, 1997·69 cites·3 claims
- 2382US5948804ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Sep 7, 1999·33 cites·12 claims
- 2481US11306075B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Apr 19, 2022·2 cites·9 claims
- 2581US5112822A(2-imidazolin-2-ylamino) quinoxaline derivatives and methods for using sameALLERGAN INC·Filed 1990·Granted May 12, 1992·41 cites·37 claims
- 2681US5066664A2-(hydroxy-2-alkylphenylamino)-oxazolines and thiazolines as anti-glaucoma and vasoconstrictive agentsALLERGAN INC·Filed 1990·Granted Nov 19, 1991·21 cites·21 claims
- 2780US6040451ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted Mar 21, 2000·29 cites·22 claims
- 2876US11472776B2Quinazolinones that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2017·Granted Oct 18, 2022·1 cites·8 claims
- 2976US2025304565A1Novel benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2025·Application pending·0 cites
- 3075US6498177B2Indole and benzothiazole derivativesSYNAPTIC PHARMA CORP·Filed 2001·Granted Dec 24, 2002·4 cites·20 claims
- 3174US6727257B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 2000·Granted Apr 27, 2004·7 cites·42 claims
- 3273US6777426B2Imidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 17, 2004·4 cites·12 claims
- 3372US5942517A5-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1997·Granted Aug 24, 1999·28 cites·29 claims
- 3471US12331043B2Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of useOLIGOMERIX INC·Filed 2022·Granted Jun 17, 2025·0 cites·5 claims
- 3571US5578611AUse of α-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1994·Granted Nov 26, 1996·21 cites·36 claims
- 3670US7208502B2Methods of treating conditions associated with an Edg-3 receptorMANIV ENERGY CAPITAL·Filed 2003·Granted Apr 24, 2007·11 cites·34 claims
- 3770US6268369B15-(heterocyclic alkyl)-6-aryl-dihydropyrimidinesSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 31, 2001·28 cites·21 claims
- 3870US6211198B1Dihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·12 cites·16 claims
- 3970US6172066B1Dihydropyrimidines and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Jan 9, 2001·15 cites·19 claims
- 4070US5326763AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1993·Granted Jul 5, 1994·28 cites·16 claims
- 4170US5231096AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1992·Granted Jul 27, 1993·24 cites·17 claims
- 4269US6303643B1Substituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Oct 16, 2001·2 cites·17 claims
- 4369US5034406AMethod for reducing or maintaining intraocular pressureALLERGAN INC·Filed 1989·Granted Jul 23, 1991·14 cites·26 claims
- 4468US5508306AAromatic amine derivativesSYNAPTIC PHARMA CORP·Filed 1993·Granted Apr 16, 1996·21 cites·16 claims
- 4567US6531471B2Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Mar 11, 2003·2 cites·55 claims
- 4666US6316637B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 1999·Granted Nov 13, 2001·8 cites·20 claims
- 4764US5418234AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted May 23, 1995·22 cites·19 claims
- 4864US5373010AMethods for using (2-imidazolin-2-ylamino) quinoxaline derivativesALLERGAN INC·Filed 1994·Granted Dec 13, 1994·22 cites·19 claims
- 4963US6436982B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 20, 2002·1 cites·3 claims
- 5062US6362182B1Morpholinone and morpholine derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Mar 26, 2002·1 cites·42 claims
Showing the top 50 of 90 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles Gluchowski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →